R. Sotto Mayor (Portela, Portugal), L. Richeldi (Modena, Italy)
The role of TTF-1 in differentiation of primary and metastatic adenocarcinomas of the lung
I. Erdem, S. Ozdogan, G. Sarac, A. Fidan, N. Ozdemir, B. Caglayan (Istanbul, Turkey)
|  |
CEA levels in the serum and induced sputum of lung cancer patients
S. Mariotta, A. Proietti, P. Bruno, A. Ricci, P. Cardelli, B. Sposato, M. Aquilini, S. Giovagnoli, G. Failla (Rome, Italy)
| |
The effect of adhesion molecule CEACAM1 and chemokine receptor CXCR4 expression on prognosis of non-small cell lung cancer
A. S. Yurdakul, N. Akyurek, S. Demirtas, J. Karakaya, L. Memis, C. Ozturk (Ankara, Turkey)
| |
The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer
A. S. Yurdakul, N. Akyurek, S. Demirtas, J. Karakaya, L. Memis, C. Ozturk (Ankara, Turkey)
| |
Is there any diagnostical significance of blood analyses in patients with lung cancer?
P. Cimen, G. Balci, E. Pala Ozden (Yenisehir, Turkey)
| |
Association of serum ROM levels with different histopathological types of lung cancer
M. Gencer, E. Ceylan, N. Aksoy, K. Uzun (Sanliurfa, Konya, Turkey)
| |
Smoking status and serum NSE, as prognostic factors in adenocarcinoma of lung
T. W. Jang, H. K. Kim, C. H. Oak, M. H. Jung (Busan, Republic Of Korea)
| |
Importance of tumour markers CYFRA 21-1 and NSE serum concentration values in diagnosis and esteem of nonmicrocelullar lung cancer expansion
V. Karlicic (Belgrade, Serbia And Montenegro)
| |
Prognostic factors in small cell lung cancer: a single-institution experience
U. Gonlugur, T. E. Gonlugur, M. Kaptanoglu, S. Elagoz, I. Akkurt, Z. Seyfikli (Sivas, Turkey)
| |
Prognostic factors for non-small cell lung cancer: an analysis of last decade
U. Gonlugur, T. E. Gonlugur, M. Kaptanoglu, S. Elagoz, I. Akkurt, Z. Seyfikli (Sivas, Turkey)
| |
Intratumoral microvessels, pTNM stage and survival in resected NSCLC
Y. G. Slavova, W. Olszewski, D. B. Petrov, V. Z. Stanoev, Z. Valerianova (Sofia, Bulgaria; Warsaw, Poland)
| |
Effects of prognostic factors on survival of the patients of non-small cell lung cancer
A. H. Ozden, H. Bayiz, B. M. Berktas, N. Basay, N. Mutluay, M. Berkoglu (Ankara, Turkey)
| |
The incidence of sick euthyroid syndrome in lung cancer patients
E. C. Seyhan, E. Cetinkaya, S. Altin, K. Epozturk, G. Safak (Istanbul, Turkey)
| |
Lung cancer in a patient with haemoptysis - relationship to current smoking status and persistence of symptom
R. A. Heinink, E. Stretton, A. Fiddler, A. Afridi, H. Moudgil, K. S. Srinivasan (Telford, United Kingdom)
| |
Clinical course of pneumonia in lung cancer
M. Taftadzhiyska, D. Karamanova, R. E. Petkov, W. Maksimov, A. Valeva (Sofia, Stara Zagora, Bulgaria)
| |
Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer
B. M. Zaric, J. Stanic, B. Andjelic, V. Canak (Sremska Kamenica, Serbia And Montenegro)
| |
Biphosphonate, ibantronate improves analgesic therapy in non-small lung cancer (NSCLC) patients with bone metastases
K. N. Syrigos, A. G. Charpidou, K. Pantazopoulos, G. Dionellis, I. Dannos, A. Rigopoulou, D. Bofos, G. Stratakos, S. Papiris (Athens, Greece)
| |
Complex palliation of advanced thracheobronchial carcinomas
L. Kotsis, M. Poczi, Z. Papai, K. Udud (Budapest, Nogradgardony, Hungary)
| |
Effects of chemotherapy on quality of life for patients with lung cancer
A. S. Yurdakul, C. Ozturk, F. Kervan, O. Yurtal (Ankara, Turkey)
| |
Comorbidity in lung cancer – operated patients. Impact on survival and prognosis
E. S. Budisin, S. M. Jovanovic, V. D. Canak, N. I. Budisin (Sremska Kamenica, Serbia And Montenegro)
| |